(EMAILWIRE.COM, March 01, 2025 ) ๐๐๐ซ๐ค๐๐ญ ๐๐ฏ๐๐ซ๐ฏ๐ข๐๐ฐ:
The Nuclear Imaging Market is projected to grow at a CAGR of 12.9% during the forecast period 2024-2031. Nuclear imaging is an advanced imaging technology that produces images by detecting radiation from different parts of the body after administering a radioactive tracer material. This technology is used to diagnose and monitor various diseases, particularly in oncology and cardiology.
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐ ๐ซ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐: https://www.datamintelligence.com/download-sample/nuclear-imaging-market
๐๐๐ซ๐ค๐๐ญ ๐๐ซ๐๐ง๐๐ฌ:
The growth of the nuclear imaging market is driven by the increasing focus on personalized medicine and advancements in radiotracer technology. Additionally, the rising prevalence of chronic diseases such as cancer and the expanding pharmaceutical industry further enhance market growth.
๐๐๐๐ก๐ง๐จ๐ฅ๐จ๐ ๐ข๐๐๐ฅ ๐๐๐ฏ๐๐ง๐๐๐ฆ๐๐ง๐ญ๐ฌ: Innovations in multimodality imaging systems, such as PET/CT, SPECT/CT, PET/MRI, and PET/SPECT/CT, are improving the accuracy of disease detection and treatment monitoring. The expansion of automation and miniaturization of cyclotrons, along with advances in radiochemistry, are making radiotracer production more practical and versatile.
๐๐ข๐ฌ๐ข๐ง๐ ๐๐ซ๐๐ฏ๐๐ฅ๐๐ง๐๐ ๐จ๐ ๐๐๐ง๐๐๐ซ ๐๐ง๐ ๐๐๐ซ๐๐ข๐๐ ๐๐ข๐ฌ๐๐๐ฌ๐๐ฌ: Nuclear imaging plays a crucial role in diagnosing and managing these conditions. Studies have shown that nuclear imaging significantly impacts patient management by improving tumor monitoring and response evaluation.
๐๐ก๐๐ฅ๐ฅ๐๐ง๐ ๐๐ฌ ๐ข๐ง ๐๐๐๐ข๐จ๐ง๐ฎ๐๐ฅ๐ข๐๐ ๐๐ฎ๐ฉ๐ฉ๐ฅ๐ฒ: A major hurdle for the market is the shortage of Tc-99m (Technetium-99), a widely used radioisotope in nuclear medicine scans. This shortage could negatively impact diagnostic imaging procedures worldwide.
๐๐๐ซ๐ค๐๐ญ ๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง:
By Product Type: Hybrid Pet, Standalone Pet, Hybrid SPECT, Standalone SPECT, Planar Scintigraphy.
By Application: Cardiology, Neurology, Oncology, Others.
By End-User: Hospitals, Research Centers, Academic Centers, Diagnostic Centers, Others.
By Region: North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.
๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐๐จ๐ซ ๐๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐๐ญ๐ข๐จ๐ง: https://www.datamintelligence.com/customize/nuclear-imaging-market
๐๐๐จ๐ ๐ซ๐๐ฉ๐ก๐ข๐๐๐ฅ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ:
๐๐จ๐ซ๐ญ๐ก ๐๐ฆ๐๐ซ๐ข๐๐ ๐๐๐๐๐ข๐ง๐ ๐ญ๐ก๐ ๐๐๐ซ๐ค๐๐ญ:
North America holds the largest share of the nuclear imaging market, driven by initiatives such as the American Medical Isotope Production Act (AMIPA) and the Uranium Lease and Take-Back (ULTB) program.
The U.S. Department of Energy (DOE) promotes domestic production of Mo-99, reducing reliance on high-enriched uranium (HEU) for medical isotope production.
Canada is one of the largest producers of Technetium-99m, further boosting the regional market.
Increased awareness and physician recommendations for nuclear medicine procedures are also contributing to market expansion.
๐๐จ๐ฆ๐ฉ๐๐ญ๐ข๐ญ๐ข๐ฏ๐ ๐๐๐ง๐๐ฌ๐๐๐ฉ๐:
The nuclear imaging market is moderately competitive, with both local and global players actively driving innovation and expansion. Major players in the market include:
Bracco Imaging SpA
Cardinal Health Inc.
GE Healthcare
Koninklijke Philips NV
Siemens Healthineers
Curium
CMR NAVISCAN (GAMMA MEDICA INC.)
Nordion (Canada) Inc.
NTP Radioisotopes SOC
Canon Medical Systems Corporation
๐๐ญ๐ซ๐๐ญ๐๐ ๐ข๐ ๐๐๐ฏ๐๐ฅ๐จ๐ฉ๐ฆ๐๐ง๐ญ๐ฌ:
Key players in the market are adopting various strategies such as product launches, acquisitions, and collaborations to strengthen their market presence. For instance, in May 2018, Curium expanded its presence in the French PET market by acquiring Cyclopharmaยs French commercial and manufacturing operations.
